Загрузка...
Obesity medications in development
INTRODUCTION: Obesity is compounded by a neurobiology that is resistant to weight loss. Therefore, the development of pharmacotherapies to address the pathology underlying the dysregulation of energy homeostasis is critical. AREAS COVERED: This review examines selected clinical trial evidence for th...
Сохранить в:
| Опубликовано в: : | Expert Opin Investig Drugs |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6990416/ https://ncbi.nlm.nih.gov/pubmed/31847611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2020.1705277 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|